237690.KQ

ST Pharm Co.,Ltd. [237690.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

237690.KQ Stock Summary

In the News

237690.KQ Financial details

Company Rating
-
Market Cap
1577.19B
Income
19.58B
Revenue
284.99B
Book val./share
-
Cash/share
-
Dividend
500
Dividend %
0.77%
Employees
566
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
68.84
Forward P/E
-
PEG
78.36
P/S
4.38
P/B
3.63
P/C
-
P/FCF
-31.83
Quick Ratio
0.49
Current Ratio
1.37
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.04K
EPS next Y
-
EPS next Q
-
EPS this Y
8.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
25.03%
Revenue Q/Q
115.61%
EPS Q/Q
167.91%
-
-
-
-
SMA20
1.83%
SMA50
8.17%
SMA100
26.78%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
5%
ROC
0.05%
Gross Margin
36%
Oper. Margin
7%
Profit Margin
7%
Payout
53%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
59900.0-99000.0
52W High
-9.6%
52W Low
+49.42%
RSI
44.2
Rel Volume
0.65
Avg Volume
232.84K
Volume
151.9K
Perf Week
-6.18%
Perf Month
-8.67%
Perf Quarter
15.63%
Perf Half Y
16.69%
-
-
-
-
Beta
0.90909
-
-
Volatility
4845.28%, 3434.08%
Prev Close
-1.43%
Price
89500
Change
-5.39%

237690.KQ Financial Performance

237690.KQ Dividend History

237690.KQ Frequently Asked Questions

What is ST Pharm Co.,Ltd. stock symbol ?

ST Pharm Co.,Ltd. is a KR stock and trading under the symbol 237690.KQ

What is ST Pharm Co.,Ltd. stock quote today ?

ST Pharm Co.,Ltd. stock price is $89500 today.

Is ST Pharm Co.,Ltd. stock public?

Yes, ST Pharm Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
MIX.JO
META
NVD.DE
VTSAX
M&M.NS
Same Sector
000710.SZ
600267.SS
INS.L
CADILAHC.NS
KALO
Same Price Range
ILCO.TA
017670.KS
282000.KS
008870.KS
017390.KS
Similar Market Cap
VOO
BAJAJ-AUTO.NS
9005.T
BPCL.NS
073240.KS

Company Profile

Healthcare Medical - Pharmaceuticals
  • Volume Average 232.84K
  • Market Capitalization 1577.19B
  • Employee 566
  • CEO Mr. Geun-Jo Im Ph.D.
  • Headquarters Seoul,KR
  • IPO Date 2016-06-23
  • Website http://www.stpharm.co.kr

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.